Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes — stopping Mounjaro and restarting later is possible, but the way you go back matters. Tirzepatide leaves your system over several weeks, and most people need to step back down to the 2.5 mg starting dose rather than picking up where they left off. A prescriber makes that call, not a general rule. These are prescription-only medicines, so any restart requires a fresh clinical review. Here's what the evidence and guidance actually say about how the body responds when treatment is paused and resumed, and what to expect when you do.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Maybe you paused because of a side effect, a surgery, a holiday that turned into a longer break, or simply the cost. Now the weight has crept back (or you're feeling ready to try again) and you're wondering whether restarting is even an option. It is, for most people. But returning to Mounjaro isn't as simple as picking up where you left off.
Tirzepatide works as a dual GIP and GLP-1 receptor agonist, slowing gastric emptying and reducing appetite. Once you stop injecting, those effects wind down over the following weeks as the medicine clears your system. Your appetite generally returns, your digestion speeds back up, and the weight-regulating signals the drug was supplementing are no longer reinforced. Understanding that reversal is the starting point for thinking clearly about a restart.
The question of whether you can stop and start Mounjaro isn't a clinical taboo, it's a practical one. The body doesn't hold a grudge. But your prescriber needs to reassess your health picture from where you are now, not where you were when you last had a pen in the fridge.
One thing catches a lot of people off guard: if you've had a significant break, your tolerance to gastrointestinal side effects resets. The nausea, indigestion and other GI effects that the slow dose-escalation schedule is designed to minimise don't stay suppressed just because you tolerated 7.5 mg or 10 mg six months ago. Jump back to a higher dose and those effects can return sharply.
The NHS tirzepatide medicines page notes that treatment starts at 2.5 mg as a tolerability dose, with the prescriber increasing gradually in four-week steps. That schedule exists specifically to let the body adjust. After a meaningful break, that adjustment process needs repeating, at least in part.
How far back you drop depends on how long you were off and what dose you were on. Someone who stopped after two weeks at 2.5 mg is in a different position from someone who paused after a year at 12.5 mg. Your prescriber considers both. If you stopped for a short gap (say, two weeks or so) the clinical picture is different again from a three-month break. Worth checking your records for the exact date of your last injection before any consultation; it takes under a minute and makes the clinical conversation much more useful.
Weight typically comes back after stopping. How quickly, and how much, varies considerably between individuals, it depends on how long you were treated, what dose you reached, your starting weight, and the diet and activity habits you maintained during treatment. The question of weight regain after stopping Mounjaro is one of the most common ones our prescribers hear, and the honest answer is that some regain is expected for most people.
That said, regain during a break doesn't automatically disqualify you from restarting. In many cases it's actually part of the clinical rationale for resuming. If you remain eligible (broadly, a BMI of 30 or above, or 27 or above with a relevant health condition) and your health picture is otherwise appropriate, a prescriber can reassess suitability. The prescriber also considers whether the reasons you stopped have resolved. A previous pancreatitis episode, for instance, is a different matter from stopping because you were travelling.
For context on the wider treatment picture, the Mounjaro treatment overview covers eligibility and what the medicine is licensed for in the UK.
Restarting Mounjaro is a prescription decision. You cannot simply order a repeat without a clinical assessment, and with a prescription-only medicine, that's not a bureaucratic inconvenience, it's the mechanism that keeps the restart safe. A prescriber needs to see where your weight sits now, review any changes to your health since you stopped, consider any new medicines you've started, and make a judgment on the appropriate dose to return to.
At nume, every repeat (including restarts after a gap) is reviewed personally by a GPhC-registered independent prescriber, not processed automatically. If you're transferring back from another provider or returning after a longer break, evidence of your previous treatment helps that review go smoothly. The process for starting Mounjaro through a regulated online pharmacy is worth reading if you're coming back after time away, as the steps are similar.
On the question of cost (which often factors into decisions to pause) our cost context page explains what a legitimate private prescription includes and why the headline price isn't always the whole picture. If you're ready to see whether restarting is clinically appropriate for you, the next step is a free consultation with our prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.